Classical transient receptor potential channel 6 (TRPC6) is a key regulator of acute hypoxic pulmonary vasoconstriction

N. Weissmann, B. Fuchs, M. Ay, R. Dumitrascu, H. Kalwa, A. Olschewski, M. Mederos y Schnitzler, U. Storch, A. Ghofrani, R. Schermuly, O. Pinkenburg, W. Seeger, F. Grimminger, T. Gudermann, A. Dietrich (Giessen, Marburg, Germany; Graz, Austria)

Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Session: Cellular and molecular aspects of pulmonary hypertension
Session type: Electronic Poster Discussion
Number: 493
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Weissmann, B. Fuchs, M. Ay, R. Dumitrascu, H. Kalwa, A. Olschewski, M. Mederos y Schnitzler, U. Storch, A. Ghofrani, R. Schermuly, O. Pinkenburg, W. Seeger, F. Grimminger, T. Gudermann, A. Dietrich (Giessen, Marburg, Germany; Graz, Austria). Classical transient receptor potential channel 6 (TRPC6) is a key regulator of acute hypoxic pulmonary vasoconstriction. Eur Respir J 2007; 30: Suppl. 51, 493

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008

Transient receptor potential vanilloid 4 channels mediate resistive breathing-induced acute lung injury.
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020


The emerging role of transient receptor potential channels in chronic lung disease
Source: Eur Respir J, 50 (2) 1601357; 10.1183/13993003.01357-2016
Year: 2017



KCNK3 channel inactivation leads to pulmonary vascular alterations in rat
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018

NMDA receptor activation promotes vascular remodeling and pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018

Endothelin-a receptor antagonists reduce eNOS gene expression in rats with chronic hypoxic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 271s
Year: 2003

Overexpression of serotonin receptor 1B (5HT-1B) responsible for overflow induced experimental pulmonary arterial hypertension development
Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation
Year: 2003


Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs
Source: Eur Respir J 2001; 17: 20-26
Year: 2001



PKC inhibits BKCa channel activity in pulmonary arterial smooth muscle cells through multiple signaling pathways
Source: Eur Respir J 2006; 28: Suppl. 50, 159s
Year: 2006

Acute hypoxia signaling in the carotid body: role of 02-sensitive ion channels
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005


Modulation of transient receptor potential vanilloid-1 (TRPV1) by inhaled prostaglandin-E2 (PGE2) and bradykinin (BK) is associated with increased cough sensitivity to capsaicin (CPS) and autonomic dysregulation of cardiac rhythm in healthy subjects
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020


Activation of transient receptor potential (TRP) channels by hypoosmolar solution: an endogenous mechanism of ATP release and afferent nerve activation
Source: International Congress 2017 – Novel studies on bronchodilators and cough
Year: 2017



Dag-dependent regulation of trpc6 in hypoxic pulmonary vasoconstriction
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009


Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008

The inhibition of MRP4, a new target in pulmonary hypertension (PH), prevents and reverses hypoxia-induced pH in mice
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009

TrkB expression is altered in hypoxia-induced pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 606s
Year: 2007

Loss of CFTR causes endothelial barrier failure in pneumonia via inhibition of WNK1 and TRPV4 activation
Source: International Congress 2017 – From respiratory muscles to acute respiratory failure
Year: 2017

In vivo blockade of KCa3.1 ion channel alleviates ER stress in type II alveolar epithelial cells and macrophages in pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019


Cystic fibrosis transmembrane conductance regulator and sphingolipids regulate hypoxic pulmonary vasoconstriction
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

The expression of TLRs and TRP channel in pulmonary sensory neuron in bleomycin induced fibrosis model.
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017